Literature DB >> 8913494

Inhibitory effect of acetylshikonin on the activation of NADPH oxidase in polymorphonuclear leukocytes in both whole cell and cell-free systems.

N Kawakami1, Y Koyama, J Tanaka, A Ohara, T Hayakawa, S Fujimoto.   

Abstract

The effects of acetylshikonin (AS) on the activation of NADPH oxidase (EC 1.6.99.6) in guinea pig polymorphonuclear leukocytes (PMNs) in both whole cell and cell-free activation systems were investigated. When PMNs were treated with AS before exposure to phorbol myristate acetate (PMA), superoxide (O2-) generation in these cells was significantly reduced, but after exposure of PMNs to PMA, inhibition of O2- generation by AS did not occur. Thiol compounds completely abolished the inhibitory effect of AS on the O2- generating activity of PMNs. In the cell-free system, AS inhibited the activation of NADPH oxidase induced by myristate in a combination of cytosol and membrane fractions obtained from intact PMNs, but did not inhibit the activity of NADPH oxidase already induced. These results suggest that AS inhibits the generation of NADPH oxidase complex in the activation of respiratory burst of PMNs, but does not directly inhibit the activity of NADPH oxidase already generated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913494     DOI: 10.1248/bpb.19.1266

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  Shikonin changes the lipopolysaccharide-induced expression of inflammation-related genes in macrophages.

Authors:  Lucia Satiko Yoshida; Tomohito Kakegawa; Yasukatsu Yuda; Hiromi Takano-Ohmuro
Journal:  J Nat Med       Date:  2017-07-11       Impact factor: 2.343

2.  Shikonin reduces oedema induced by phorbol ester by interfering with IkappaBalpha degradation thus inhibiting translocation of NF-kappaB to the nucleus.

Authors:  I Andújar; M C Recio; T Bacelli; R M Giner; J L Ríos
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma.

Authors:  Chen-Chen Lee; Chien-Neng Wang; Yu-Ting Lai; Jaw-Jou Kang; Jiunn-Wang Liao; Bor-Luen Chiang; Hui-Chen Chen; Yu-Wen Cheng
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  Evaluation of radical scavenging properties of shikonin.

Authors:  Lucia S Yoshida; Shunji Kohri; Shohko Tsunawaki; Tomohito Kakegawa; Taizo Taniguchi; Hiromi Takano-Ohmuro; Hirotada Fujii
Journal:  J Clin Biochem Nutr       Date:  2014-08-05       Impact factor: 3.114

5.  Inhibition of neutrophil superoxide generation by shikonin is associated with suppression of cellular Ca(2+) fluxes.

Authors:  Kimiko Kazumura; Lucia Satiko Yoshida; Akiko Hara; Hiroshi Tsuchiya; Naokazu Morishita; Hirokazu Kawagishi; Tomohito Kakegawa; Yasukatsu Yuda; Hiromi Takano-Ohmuro
Journal:  J Clin Biochem Nutr       Date:  2016-06-18       Impact factor: 3.114

Review 6.  Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review.

Authors:  Zhiqin Zhang; Jie Bai; Yawen Zeng; Mengru Cai; Yu Yao; Huimin Wu; Longtai You; Xiaoxv Dong; Jian Ni
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.